Zizipho Mmango - Aspen Pharmacare Group Officer

APN Stock   17,378  831.00  5.02%   

Executive

Zizipho Mmango is Group Officer of Aspen Pharmacare Holdings
Age 38
Phone27 31 580 8600
Webhttps://www.aspenpharma.com

Aspen Pharmacare Management Efficiency

The company has return on total asset (ROA) of 0.0499 % which means that it generated a profit of $0.0499 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.095 %, meaning that it generated $0.095 on every $100 dollars invested by stockholders. Aspen Pharmacare's management efficiency ratios could be used to measure how well Aspen Pharmacare manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

EXECUTIVE Age

Collin GovenderAllied Electronics
N/A
Johan GellatlyAllied Electronics
N/A
LLB BAAfroCentric Investment Corp
60
Werner KappAllied Electronics
N/A
Gawie CAAfroCentric Investment Corp
49
Lee CallakoppenAfroCentric Investment Corp
N/A
Tyron SwanepoelCA Sales Holdings
N/A
Tobie PreezAfroCentric Investment Corp
55
DIP ProcAfroCentric Investment Corp
N/A
Chetan GopalCA Sales Holdings
N/A
Herman SmitCA Sales Holdings
N/A
Piet PieterseCA Sales Holdings
56
Pierre BruwerAllied Electronics
N/A
Bernadien NaudeCA Sales Holdings
N/A
Yolandi ZweelAfroCentric Investment Corp
N/A
Pam XabaAllied Electronics
N/A
Leslie MoodleyAllied Electronics
N/A
DebraLynn MaraisAllied Electronics
N/A
Chad BakerAllied Electronics
N/A
Claude HassettCA Sales Holdings
N/A
MA EMBAAfroCentric Investment Corp
N/A
Aspen Pharmacare Holdings (APN) is traded on Johannesburg Exchange in South Africa and employs 8,580 people.

Management Performance

Aspen Pharmacare Holdings Leadership Team

Elected by the shareholders, the Aspen Pharmacare's board of directors comprises two types of representatives: Aspen Pharmacare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspen. The board's role is to monitor Aspen Pharmacare's management team and ensure that shareholders' interests are well served. Aspen Pharmacare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspen Pharmacare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sean Capazorio, Group Director
Lorraine Hill, Group Pharmacist
Zizipho Mmango, Group Officer
Carnie Linde, Group Head
BCom BCom, Group Advisor
Dip MBA, Group Officer
ACIS BProc, Group Sec
Stavros Nicolaou, Group Trade
Trevor Ziman, Regional Pacific
Stephen Saad, Group Director

Aspen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aspen Pharmacare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Aspen Stock

Aspen Pharmacare financial ratios help investors to determine whether Aspen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aspen with respect to the benefits of owning Aspen Pharmacare security.